Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CI-719

Known as: CI 719, CI719 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and… Expand
  • figure 1
  • table I
  • table 2
  • table 1
  • figure 2
Is this relevant?
1976
1976
In the search for compounds which decrease plasma lipids in man and animals, gemfibrozil was selected from a series of related… Expand
  • table I
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1976
1976
Alkylation reactions are among the most fundamental and general procedures available to synthetic chemists for the purpose of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1976
1976
The hypolipidaemic effect of a new drug, gemfibrozil (CI-719), was studied for 20 weeks in 20 patients with primary type IIb, III… Expand
  • figure I
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1976
1976
Clofibrate is an established hypolipidemic drug which lowers plasma triglyceride concentrations. The mechanism of its… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1976
1976
Gemfibrozil (CI-719) was recommended in March 1971, and approved by the Research Committee of Parke, Davis for clinical trial in… Expand
Is this relevant?
1976
1976
Changes in triglycerides after four to eight weeks' intake of 800 mg of CI-719 are shown in Table 1. After four weeks a decrease… Expand
  • table 1
  • table I
Is this relevant?